共 10 条
[2]
Outcome; quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03).[J].Gianfranco A. Pesce;Dirk Klingbiel;Karin Ribi;Abderahim Zouhair;Roger von Moos;Marc Schlaeppi;Clemens B. Caspar;Natalie Fischer;Sandro Anchisi;Solange Peters;Richard Cathomas;Jürg Bernhard;Nina M. Kotrubczik;Gianni
[5]
Factors associated with the development of brain metastases.[J].Jessica L.Hubbs;Jessamy A.Boyd;DonnaHollis;Junzo P.Chino;MertSaynak;Chris R.Kelsey.Cancer.2010, 21
[6]
Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer.[J].Si-yu Wang;Xiong Ye;Wei Ou;Yong-bin Lin;Bin-bin Zhang;Hua Yang.Lung Cancer.2008, 2
[7]
Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment.[J].Giovanni Luca Ceresoli M.D.;Michele Reni M.D.;Giuseppe Chiesa M.D.;Angelo Carretta M.D.;Stefano Schipani M.D.;Paolo Passoni M.D.;Angelo Bolognesi M.D.;Piero Zannini M.D.;Eugenio Villa M.D..Cancer.2002, 3
[9]
Patterns of relapse of N2 nonsmall‐cell lung carcinoma patients treated with preoperative chemotherapy.[J].F. Andre M.D.;D. Grunenwald M.D.;J. L. Pujol M.D.;P. Girard M.D.;A. Dujon M.D.;L. Brouchet M.D.;P. Y. Brichon M.D.;V. Westeel M.D.;T. Le Chevalier M.D..Cancer.2001, 12

